A Phase 2 Randomized Trial of Neoadjuvant Enoblituzumab versus Standard of Care in Men with High-Risk Localized Prostate Cancer: The Help Elucidate & Attack Longitudinally (HEAT) Prostate Cancer Randomized Study

Project: Research project

Project Details

StatusActive
Effective start/end date4/1/247/4/28

Funding

  • Johns Hopkins University (2006433781 // 2006433781)
  • Macrogenics, Inc. (2006433781 // 2006433781)